polycythemia: Abnormally high mass or concentration of red blood cells in the blood, either due to an increase in erythropoiesis or a decrease in plasma volume.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
832 |
4. Check minimum number of eventsNone |
832 |
5. Include endpointsNone |
832 |
6. Filter based on genotype QC (FinnGen only) |
832 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D75
- Name in latin
- Polycythaemia secundaria
Similar endpoints
↥List of similar endpoints to
Secondary polycythaemia
based on the number of shared cases.
Similar with more cases:
- Other diseases of blood and blood-forming organs
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5793 | 1925 | 3795 |
| Only index persons | 4662 | 1564 | 3098 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.06 | 0.11 |
| Only index persons | 0.10 | 0.06 | 0.12 |
| Median age at first event (years) | |||
| Whole population | 58.75 | 60.79 | 57.65 |
| Only index persons | 57.47 | 60.07 | 56.16 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 832 | 289 | 543 |
| Unadjusted period prevalence (%) | 0.19 | 0.10 | 0.24 |
| Median age at first event (years) | 57.94 | 56.36 | 58.78 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 762
- Matched controls
- 7618
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D75.1
ICD-10 Finland
Secondary polycythaemia
4503599627370496.0
323.0
703
*
D45
ICD-10 Finland
Polycythaemia vera
57.3
85.1
100
20
XW000
NOMESCO Finland
Bone marrow biopsy
13.1
65.7
120
107
TPH00
NOMESCO Finland
Phlebotomy
71.0
46.7
53
8
28900
ICD-8 Finland
Other disease of blood and blood-forming organs, Polycythaemia, secondary
+∞
44.2
42
*
D75.0
ICD-10 Finland
Familial erythrocytosis
+∞
42.1
40
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
+∞
42.1
40
*
SPAT1074
SPAT
Venesection
48.8
38.3
46
10
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
5.0
32.0
110
249
T90
ICPC
Diabetes non-insulin dependent
2.9
31.7
244
1071
G47.3
ICD-10 Finland
Sleep apnoea
2.8
31.2
256
1169
103
Kela drug reimbursment
Diabetes, insulin-treated
2.6
27.7
267
1320
A10BA02
ATC
metformin; oral
2.5
27.1
267
1330
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
26.2
233
1095
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.6
25.7
243
1179
R71
ICD-10 Finland
Abnormality of red blood cells
89.6
23.8
26
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.0
22.4
143
542
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
23.1
20.5
29
13
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
18.7
456
3257
SPAT1262
SPAT
Handing over of treatment supplies
2.4
18.6
176
832
D75.2
ICD-10 Finland
Essential thrombocytosis
184.0
17.6
18
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.6
17.5
148
655
R5140
NOMESCO Finland
Monitoring the use of the aid
2.8
17.5
122
484
C03DA01
ATC
spironolactone; oral
3.0
17.4
109
405
I50.9
ICD-10 Finland
Heart failure, unspecified
2.7
17.3
133
558
L01XX05
ATC
hydroxycarbamide; oral
16.4
17.1
27
17
A10BH01
ATC
sitagliptin; oral
3.0
17.1
105
383
C03CA01
ATC
furosemide; systemic
2.1
17.0
233
1306
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.1
16.9
229
1277
C07AB07
ATC
bisoprolol; oral
1.9
16.9
375
2542
E29.1
ICD-10 Finland
Testicular hypofunction
10.7
16.8
32
31
R03BB04
ATC
tiotropium bromide; inhalant
2.9
16.6
107
403
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
16.3
354
2371
J96.1
ICD-10 Finland
Chronic respiratory failure
6.6
15.7
40
63
SPAT1249
SPAT
Treatment-related counselling outside office
1.9
14.4
296
1918
R03AC02
ATC
salbutamol; inhalant
1.8
14.1
375
2647
C07AB02
ATC
metoprolol; systemic
2.1
13.7
173
925
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
13.6
87
327
M04AA01
ATC
allopurinol; systemic
2.4
13.4
121
550
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.7
13.4
60
174
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.7
13.4
99
405
A10BK01
ATC
dapagliflozin; oral
4.1
13.1
51
131
B99
ICPC
Blood/lymph/spleen disease other
15.7
12.7
20
13
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
32.6
12.6
16
5
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
12.5
97
407
205
Kela drug reimbursment
Chronic hypertension
1.9
12.4
225
1377
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.8
12.3
52
144
C01AA05
ATC
digoxin; systemic
2.8
11.9
81
315
C08CA01
ATC
amlodipine; oral
1.8
11.6
274
1825
R06.0
ICD-10 Finland
Dyspnoea
1.9
11.6
188
1104
A10AE04
ATC
insulin glargine; parenteral
2.6
11.6
91
384
2890X
ICD-9 Finland
Other diseases of blood and blood-forming organs, Polycythaemia, secondary[ERYTHROCYTOSIS SECUNDARIA, NUD]
+∞
11.5
11
*
D58.2
ICD-10 Finland
Other haemoglobinopathies
+∞
11.5
11
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.2
11.2
42
105
121
Kela drug reimbursment
Severe hypofunction of sexual glands
8.0
10.9
24
31
A10BJ02
ATC
liraglutide; parenteral
5.0
10.9
34
70
E66.9
ICD-10 Finland
Obesity, unspecified
4.4
10.7
38
90
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
8.7
10.6
22
26
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.2
10.5
54
175
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
111.4
10.4
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
10.4
319
2282
E66.00
ICD-10 Finland
Metabolic syndrome
3.3
10.3
52
167
XG466
NOMESCO Finland
Sleep oxymetry
3.6
10.2
45
130
A10BK03
ATC
empagliflozin; oral
2.6
10.2
74
300
E66.01
ICD-10 Finland
Obesity due to excess calories
2.8
10.1
64
239
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
3.3
10.1
50
158
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.2
9.9
104
508
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.2
9.8
50
162
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.6
9.8
71
286
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
5.4
9.7
28
53
C02AC05
ATC
moxonidine; oral
3.4
9.7
46
141
207
Kela drug reimbursment
Chronic arrhythmias
2.1
9.7
121
640
C09AA05
ATC
ramipril; oral
1.8
9.6
189
1177
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
9.5
123
658
H02AB06
ATC
prednisolone; systemic
1.6
9.4
329
2422
E66.8
ICD-10 Finland
Other obesity
3.3
9.3
46
146
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
13.9
9.2
15
11
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
9.0
143
826
ZXE00
NOMESCO Finland
One hour or less
1.6
9.0
279
1981
M10.9
ICD-10 Finland
Gout, unspecified
2.7
8.9
61
241
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
8.9
231
1559
N07BA03
ATC
varenicline; oral
3.0
8.8
50
173
A10BJ06
ATC
semaglutide; parenteral
3.8
8.5
35
96
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
27.8
8.5
11
*
Q21.81
ICD-10 Finland
Eisenmenger's syndrome
+∞
8.3
8
*
B01AA03
ATC
warfarin; systemic
1.8
8.2
161
996
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.1
8.2
21
35
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
8.1
177
1131
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.0
8.1
102
539
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
11.9
8.1
14
12
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.4
8.1
38
117
WX780
NOMESCO Finland
Remote monitoring CPAP
3.0
8.1
44
151
I50.0
ICD-10 Finland
Congestive heart failure
2.5
8.0
61
253
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
22.3
8.0
11
5
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.8
8.0
164
1029
M54.5
ICD-10 Finland
Low back pain
1.6
7.9
222
1527
C09AA02
ATC
enalapril; systemic
1.8
7.8
151
926
M79.6
ICD-10 Finland
Pain in limb
1.6
7.8
232
1616
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.4
7.7
22
42
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
4.0
7.6
29
75
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
7.4
122
709
Y28
ICPC
Limited function/disability (Y)
13.5
7.4
12
9
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
+∞
7.3
7
*
SPAT1254
SPAT
Administration of medicine
1.9
7.3
103
568
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
7.2
103
571
WX723
NOMESCO Finland
CPAP therapy
3.0
7.2
41
143
A10BB12
ATC
glimepiride; oral
2.4
7.2
59
256
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.9
7.1
102
565
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
20.2
7.1
10
5
A02BC02
ATC
pantoprazole; systemic
1.5
7.1
450
3719
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.2
7.1
35
113
C10AA01
ATC
simvastatin; oral
1.5
7.0
306
2326
E66
ICD-10 Finland
Obesity
3.3
6.9
32
99
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.9
6.8
108
620
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.5
6.8
51
213
SPAT1263
SPAT
Sampling
1.5
6.7
278
2086
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
6.7
100
562
160
Kela drug reimbursment
exenatide
4.1
6.6
24
60
N06AX11
ATC
mirtazapine; oral
1.6
6.6
221
1577
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
6.6
44
173
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
6.6
63
297
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.9
6.4
37
131
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
6.4
117
703
D70.82
ICD-10 Finland
Drug-induced neutropenia
70.4
6.4
7
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.0
6.4
19
39
C08CA02
ATC
felodipine; oral
2.1
6.2
70
355
L28
ICPC
Limited function/disability (L)
1.8
6.2
105
615
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.0
6.2
76
400
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
6.2
244
1801
I11.9
ICD-10 Finland
Hypertensive heart disease without (congestive) heart failure
2.7
6.2
38
143
WX110
NOMESCO Finland
Local anesthesy
1.5
6.2
472
4002
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
330
79
68.57
307.65
1.1
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
397
107
70.05
307.65
1.4
1.2
u/l
15.6
51.1
1.17
347
96
(3042111) Morphology [Interpretation] in Bone marrow Narrative
93
90
11.51
85.71
1.1
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
250
718
4.55
80.55
2.8
4.0
u/l
236.0
249.9
0.48
231
679
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
279
875
4.29
79.89
2.3
2.5
%
25.3
23.4
1.21
250
751
(3004789) Transferrin [Mass/volume] in Serum or Plasma
283
927
4.11
75.83
2.2
2.4
g/l
2.6
2.3
12.93
260
859
(3006315) Basophils [#/volume] in Blood
597
3220
4.02
74.87
6.2
5.7
e9/l
0.1
0.0
12.78
541
2774
(3001604) Monocytes [#/volume] in Blood
589
3207
3.86
71.43
6.3
5.7
e9/l
0.7
0.6
6.64
537
2758
(3019198) Lymphocytes [#/volume] in Blood
596
3290
3.86
70.30
6.2
5.8
e9/l
2.1
2.0
0.28
554
2890
(3013115) Eosinophils [#/volume] in Blood
600
3332
3.87
69.99
6.6
5.9
e9/l
0.2
0.2
2.37
557
2927
(3022948) Iron [Moles/volume] in Serum or Plasma
289
1017
3.82
68.99
2.4
2.5
umol/l
15.6
13.4
4.54
266
941
(3022096) Basophils/100 leukocytes in Blood
549
2933
3.56
66.87
6.5
5.9
%
0.8
0.7
3.68
520
2740
(3019069) Monocytes/100 leukocytes in Blood
559
3032
3.57
66.18
6.8
6.1
%
8.6
8.8
0.95
531
2845
(3006504) Eosinophils/100 leukocytes in Blood
557
3018
3.56
65.97
6.6
5.8
%
2.9
2.9
0.13
529
2812
(42870588) Differential panel, method unspecified - Blood
451
2159
3.38
65.37
6.3
5.6
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
562
3104
3.50
63.61
6.8
5.9
%
27.1
27.2
0.13
534
2894
(3018010) Neutrophils/100 leukocytes in Blood
546
3056
3.29
58.50
6.3
5.8
%
57.8
57.7
0.06
515
2864
(3013650) Neutrophils [#/volume] in Blood by Automated count
618
3725
3.56
58.40
9.7
9.0
e9/l
4.6
4.2
4.45
558
3249
(3032868) Hemoglobin electrophoresis panel in Blood
60
8
80.86
53.78
1.4
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
208
715
3.55
49.63
2.2
2.6
%
1.8
1.8
0.09
179
644
(40760892) CBC W Ordered Manual Differential panel - Blood
313
1402
2.98
47.49
4.3
4.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
82
150
5.96
43.65
3.9
3.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
53
61
9.21
42.68
1.1
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
79
145
5.91
41.88
5.7
4.4
mmol/l
3.3
2.6
0.73
55
98
(3023520) Reticulocytes [#/volume] in Blood
161
527
3.55
40.85
2.6
2.6
e9/l
95.1
69.7
10.79
127
408
(3021589) Normoblasts [#/volume] in Blood
473
2844
2.54
37.52
13.2
9.4
e9/l
0.0
0.0
0.53
411
2327
(3010421) pH of Blood
82
177
5.03
36.27
5.6
4.2
ph
7.4
7.4
0.76
76
142
(3012516) Albumin [Mass/volume] in Urine
366
2004
2.48
34.88
3.7
3.3
mg/l
80.0
248.2
1.43
247
1329
(3026493) Urate [Moles/volume] in Serum or Plasma
336
1783
2.48
34.12
3.2
2.6
umol/l
2875.4
6379.0
0.98
295
1558
(3001122) Ferritin [Mass/volume] in Serum or Plasma
436
2619
2.40
33.32
3.2
2.7
ug/l
140.7
149.6
0.31
402
2396
(3020682) Albumin/Creatinine [Ratio] in Urine
373
2108
2.39
32.56
5.0
4.0
mg/mmol
13.6
8.7
1.04
237
1379
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
522
3427
2.40
32.08
6.7
6.6
umol/l
14.2
11.6
4.82
509
3257
(3009508) Creatinine [Moles/volume] in Urine
370
2121
2.34
30.82
3.7
3.2
mmol/l
8.3
8.0
0.43
295
1775
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
61
117
5.55
30.74
2.9
3.2
%
57.8
57.6
0.03
61
117
(3030905) Polymorphonuclear cells [#/volume] in Blood
58
113
5.44
28.71
2.7
2.9
e9/l
4.5
4.4
0.12
58
113
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
666
5040
2.61
27.49
9.1
7.7
u/l
82.2
78.7
0.85
637
4734
(3018418) pH of Serum or Plasma
327
1873
2.23
26.29
4.6
4.1
ph
7.4
7.4
0.18
106
348
(40761536) Microorganisms panel - Urine sediment
135
523
2.89
25.12
4.6
3.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
129
505
2.84
23.47
3.7
3.8
mmol/l
1.2
1.2
0.17
116
448
(3009214) Lutropin [Units/volume] in Serum or Plasma
68
185
3.91
22.25
1.7
1.4
u/l
6.0
8.4
1.01
52
150
(40767503) Oxygen content in Capillary blood by calculation
58
141
4.35
22.06
3.2
2.4
%
20.3
16.2
7.53
33
75
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
43
81
5.54
22.04
1.9
2.1
pg
33.1
33.2
0.04
43
81
(3013826) Glucose [Moles/volume] in Serum or Plasma
541
3924
2.08
21.91
6.6
5.1
mmol/l
7.2
6.8
3.64
530
3701
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
433
2910
2.02
21.57
7.1
6.5
mmol/l
1.2
1.2
0.40
397
2638
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
321
1938
2.07
21.56
3.9
3.0
ng/l
1466.9
1354.3
0.22
267
1635
(3024561) Albumin [Mass/volume] in Serum or Plasma
421
2803
2.02
21.51
4.9
4.9
g/l
35.8
35.6
0.34
387
2604
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
463
3202
2.01
21.08
7.3
7.1
mmol/l
1.2
1.2
0.08
361
2726
(3019060) Gas panel - Arterial blood
115
454
2.78
20.48
5.3
5.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
323
1989
2.02
20.26
4.1
3.2
e6/l
131.9
92.0
0.26
258
1537
(36304419) Bacteria [Presence] in Urine
290
1748
2.01
19.08
3.9
3.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
408
2768
1.93
18.93
12.4
9.0
inr
1.3
1.3
0.13
162
789
(3017446) Testosterone [Moles/volume] in Serum or Plasma
153
723
2.37
18.67
4.5
2.2
nmol/l
13.7
13.3
0.21
136
651
(3000850) Epithelial cells [#/volume] in Urine
239
1355
2.07
18.54
3.5
2.6
e6/l
4.2
4.2
0.02
209
1192
(3002179) Metamyelocytes/100 leukocytes in Blood
115
481
2.61
18.21
3.8
4.1
%
1.2
0.4
1.02
38
122
(21494434) Karyotype in Bone marrow
33
58
5.88
18.17
1.0
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
294
1811
1.96
17.96
4.0
3.1
e6/l
0.5
0.5
0.00
231
1364
(3025159) Blasts/100 leukocytes in Blood
113
473
2.61
17.85
3.7
4.4
%
0.1
0.1
0.37
39
127
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
600
4684
2.01
17.75
4.5
3.5
pmol/l
15.2
14.8
2.68
538
4231
(3017181) Myelocytes/100 leukocytes in Blood
123
538
2.51
17.73
3.7
4.2
%
0.9
0.8
0.19
48
167
(3021901) Oxygen saturation in Capillary blood
50
131
4.00
17.21
2.9
2.5
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
117
511
2.50
16.89
3.8
4.3
%
0.1
0.1
0.18
44
153
(3013707) Erythrocyte sedimentation rate by Westergren method
607
4803
1.98
16.65
4.2
3.9
mm/h
7.4
11.9
15.64
563
4423
(3026782) Osmolality of Urine
222
1280
2.00
16.13
3.3
2.8
mosm/kgh2o
539.0
572.5
1.45
187
1082
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
752
2.20
15.36
2.5
2.8
umol/l
9.2
8.8
0.09
133
666
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
101
431
2.53
15.27
4.2
3.5
mmol/l
2.9
1.8
1.94
76
316
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
63
213
3.12
14.74
2.9
1.9
pmol/l
186.0
212.0
0.97
63
201
(3018095) Leukocytes [#/volume] in Urine
337
2286
1.80
14.50
4.7
3.7
e6/l
110.7
95.3
0.17
265
1646
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
345
2372
1.78
14.07
4.0
3.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
48
141
3.55
14.04
2.2
2.3
g/l
162.7
131.4
10.06
43
105
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
324
2192
1.78
13.93
3.7
3.5
u/l
34.5
34.5
0.00
314
2078
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
54
179
3.16
13.06
1.8
3.1
mg/l
1.5
1.6
0.44
43
162
(3009343) pH of Capillary blood
100
457
2.35
12.97
4.4
3.4
ph
7.4
7.4
0.69
29
55
(3003396) Base excess in Arterial blood by calculation
148
792
2.06
12.97
7.7
9.1
mmol/l
1.9
1.1
1.15
117
624
(3003458) Phosphate [Moles/volume] in Serum or Plasma
159
876
2.01
12.85
5.6
6.1
mmol/l
1.0
1.0
0.33
152
815
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
134
696
2.10
12.70
4.9
3.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
683
5824
1.96
12.53
5.5
4.3
mu/l
1.9
2.1
0.51
610
5281
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
367
2631
1.71
12.47
5.0
3.5
ng/l
24.6
45.3
3.82
290
1873
(3019977) pH of Arterial blood
21
37
5.80
11.52
2.5
4.6
ph
7.4
7.4
0.35
16
12
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
226
1453
1.76
11.12
1.9
1.7
mg/l
0.9
1.2
2.36
171
1129
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
23
46
5.11
11.04
1.6
1.8
nmol/l
18.6
19.6
0.17
23
41
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
16
22
7.40
11.01
1.6
2.8
u/l
199.3
203.6
0.10
16
22
(3037467) Urinalysis macro (dipstick) panel - Urine
544
4411
1.67
10.95
4.7
4.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
238
1560
1.74
10.91
7.8
6.6
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
248
1646
1.72
10.86
4.2
4.0
%
83.4
89.1
2.57
240
1611
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
297
2071
1.68
10.81
2.9
2.6
u/l
50.5
57.2
3.43
270
1935
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
178
1084
1.82
10.44
2.2
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
250
1688
1.69
10.17
4.5
3.7
estimate
0.0
0.0
0.69
107
556
(3044889) 12 lead EKG panel
572
4742
1.66
10.14
5.2
3.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
49
180
2.83
9.93
3.6
3.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
250
1707
1.66
9.66
3.4
3.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
704
6209
1.87
9.66
8.4
5.8
mmol/mol
42.9
40.1
7.88
640
5771
(3012095) Magnesium [Moles/volume] in Serum or Plasma
173
1075
1.77
9.40
3.8
3.4
mmol/l
0.8
0.8
0.43
164
1016
(3023368) Bacteria identified in Blood by Culture
269
1882
1.63
9.40
5.0
4.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
25
62
4.13
9.30
1.7
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
735
6596
1.98
9.24
19.8
14.1
mg/l
20.2
25.0
4.56
645
5235
(3020891) Body temperature
62
267
2.43
9.17
6.1
4.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
252
1744
1.64
9.16
4.1
3.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
68
306
2.33
9.12
3.3
3.4
pmol/l
4.6
4.6
0.10
57
275
(3000492) Spirometry study
118
662
1.91
8.89
1.6
1.4
—
—
—
0
0
(3013512) EKG study
274
1950
1.60
8.83
4.8
3.9
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
709
6312
1.83
8.82
20.5
13.0
ml/min/173m2
77.9
81.4
4.13
625
5223
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
229
1561
1.64
8.78
2.7
2.1
mg/l
5.3
3.1
6.88
198
1330
(3009261) Glucose [Presence] in Urine by Test strip
405
3164
1.55
8.62
4.2
3.5
estimate
0.0
0.0
0.50
109
550
(3035350) Ketones [Presence] in Urine by Test strip
401
3133
1.54
8.48
4.2
3.4
estimate
0.0
0.0
0.00
123
575
(3021601) Nitrite [Presence] in Urine by Test strip
400
3127
1.54
8.42
5.3
4.7
estimate
0.0
0.0
0.00
122
584
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
25
67
3.82
8.39
1.4
1.5
nmol/l
0.2
0.3
0.36
19
53
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
34
112
3.12
8.36
1.8
1.8
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
331
2487
1.55
8.32
2.5
2.2
nmol/l
72.9
75.6
1.04
296
2204
(3051611) Lipemic interference index of Serum or Plasma
24
63
3.89
8.29
3.5
4.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
629
5451
1.63
8.27
25.2
17.2
%
14.4
13.7
14.51
620
5337
(3005719) IgG [Mass/volume] in Serum or Plasma
93
498
1.98
8.01
2.2
2.4
g/l
9.7
10.8
1.87
81
457
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
25
70
3.65
7.90
2.1
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
109
625
1.86
7.65
2.1
2.4
g/l
0.2
0.2
0.49
104
584
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
324
2460
1.52
7.58
4.2
3.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
18
41
4.47
7.45
2.2
3.4
—
—
—
0
0
(3000012) Reticulocyte production index
15
30
5.07
7.20
1.8
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
34
4.78
7.19
1.4
1.6
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
201
2.42
7.09
2.9
4.2
mg/l
37.4
31.9
0.40
35
166
(3034860) Kappa light chains.free [Mass/volume] in Serum
47
201
2.42
7.09
2.9
4.2
mg/l
51.4
91.4
0.66
34
164
(3019550) Sodium [Moles/volume] in Serum or Plasma
745
6836
1.86
7.02
24.9
16.6
mmol/l
139.6
139.7
0.31
729
6666
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
24
71
3.45
7.01
1.3
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
99
566
1.85
7.01
8.5
9.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
195
1359
1.57
6.60
1.9
1.7
pmol/l
89189615.0
28144666.4
0.46
148
1137
(3020630) Protein [Mass/volume] in Serum or Plasma
90
509
1.86
6.59
2.3
3.0
g/l
64.8
66.5
1.09
81
465
(3028026) IgM [Mass/volume] in Serum or Plasma
75
401
1.96
6.50
1.5
1.6
g/l
1.1
1.6
1.11
69
372
(3023103) Potassium [Moles/volume] in Serum or Plasma
744
6854
1.81
6.49
25.3
16.7
mmol/l
4.0
4.0
0.12
728
6677
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
33
4.61
6.48
1.4
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
703
6387
1.65
6.34
4.9
4.0
mmol/l
1.6
1.3
12.30
633
5885
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
22
66
3.40
6.31
1.2
1.3
nmol/l
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
282
2148
1.47
6.22
3.4
3.4
mmol/l
2.4
2.3
1.23
245
1867
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
530
4546
1.46
6.19
3.8
3.2
u/l
64.8
53.9
1.49
486
4265
(3031040) Bacteria [#/volume] in Urine by Automated count
489
4136
1.44
6.13
5.7
4.2
e6/l
221.2
1437.4
0.54
11
62
(40760888) Immunoglobulin light chains.free panel - Serum
36
146
2.53
6.10
2.8
4.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
102
615
1.75
6.05
4.6
3.6
mmol/l
2.1
2.1
0.03
81
489
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
331
2613
1.44
6.00
1.9
2.0
pmol/l
89.6
93.9
0.99
185
1387
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
720
6617
1.65
5.77
5.4
4.4
mmol/l
1.2
1.4
40.61
653
6109
(3027456) Digoxin [Moles/volume] in Serum or Plasma
33
132
2.56
5.76
3.8
2.9
nmol/l
0.8
0.9
0.39
26
105
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
723
6660
1.65
5.64
5.4
4.4
mmol/l
4.4
4.6
9.67
661
6185
(3004775) Volume in Urine collected for unspecified duration
20
61
3.33
5.61
2.4
2.3
ml
572.3
651.3
0.57
12
38
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
733
6778
1.68
5.60
6.1
4.9
mmol/l
2.6
2.8
3.13
664
6254
(3016750) Collection duration of Urine
17
47
3.67
5.50
2.1
2.3
min
499.5
491.2
—
10
33
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
154
2.40
5.48
1.8
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
89
532
1.75
5.44
3.5
2.9
ng/l
297.0
186.9
1.57
78
481
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
264
2032
1.44
5.36
2.4
2.1
u/l
283.2
275.8
0.03
239
1916
(40768804) Tissue Pathology biopsy report
310
2457
1.42
5.35
2.2
2.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
74
421
1.83
5.34
2.5
2.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
136
913
1.59
5.34
1.9
1.9
%
1.5
1.5
0.03
116
801
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
118
766
1.63
5.31
2.1
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
120
784
1.62
5.27
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
117
761
1.63
5.23
2.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
35
152
2.36
5.16
1.8
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
25
92
2.77
5.14
2.1
1.6
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
236
1792
1.44
5.12
1.7
1.7
mmol/l
1.8
1.4
3.11
174
1516
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
40
3.80
5.11
1.4
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
6
13.44
5.08
1.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
50
3.45
5.05
1.9
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
129
867
1.58
5.03
37.9
22.4
inr
1.9
1.3
3.02
23
120
(3000570) Elastase.pancreatic [Mass/mass] in Stool
39
181
2.21
4.95
1.7
1.5
ug/g
292.9
272.6
0.21
22
109
(3037522) Nuclear Ab [Titer] in Serum
123
824
1.58
4.86
1.3
1.3
titre
344.8
440.7
0.52
21
166
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
24
90
2.72
4.78
1.6
1.7
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
57
313
1.88
4.61
5.2
3.9
mmol/l
23.8
24.2
0.39
48
280
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
74
442
1.74
4.56
4.2
4.1
ng/l
97.2
90.5
0.27
59
392
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
20
70
2.90
4.52
1.9
1.3
pmol/l
113.1
57.6
0.63
14
21
(40768797) Stomach Pathology biopsy report
128
882
1.53
4.46
1.2
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
44
224
2.02
4.43
4.3
2.6
u/ml
0.4
0.3
0.61
31
111
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
125
2.37
4.38
1.1
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
23
89
2.63
4.33
1.3
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
160
1162
1.47
4.32
3.0
3.2
mmol/l
2.5
2.4
2.40
131
1019
(1761868) Lipid panel - Serum or Plasma
306
2494
1.36
4.24
3.6
2.8
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
158
1151
1.46
4.20
1.3
1.4
g/l
2.7
2.6
0.28
107
724
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
194
2.06
4.19
2.4
2.4
ug/min
45.6
100.1
1.38
19
116
(40761511) CBC panel - Blood by Automated count
736
6906
1.57
4.19
19.8
13.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
117
805
1.53
4.10
1.5
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
753
7109
1.62
4.10
14.2
10.3
u/l
34.1
28.5
3.54
724
6873
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
698
6485
1.47
4.08
6.0
4.5
mmol/l
6.5
6.0
10.96
626
5922
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
10
8.06
4.06
1.3
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
29
132
2.24
3.90
1.7
1.8
iu/l
3.1
5.8
1.27
11
40
(46235355) HIV 1 and 2 tests - Meaningful Use set
135
967
1.47
3.90
1.8
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
66
402
1.70
3.82
2.7
2.9
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
15
49
3.10
3.82
18.8
17.6
nmol/l
1166.7
1455.5
0.86
15
49
(4010399)
75
475
1.64
3.75
1.7
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
141
2.17
3.75
1.3
1.2
e6/l
9.6
12.6
0.13
25
110
(3018405) Lactate [Moles/volume] in Arterial blood
46
255
1.85
3.66
5.0
4.1
mmol/l
1.4
1.4
0.13
46
248
(3036489) Thrombin time
44
241
1.87
3.64
2.4
2.0
s
22.4
21.2
0.34
38
214
(21494755) Public health laboratory ask at order entry panel
38
685
0.53
3.62
1.5
1.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
142
1046
1.43
3.54
2.7
2.1
s
32.6
29.8
3.22
137
1017
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23
100
2.34
3.45
1.3
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
37
195
1.94
3.44
1.7
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
55
329
1.72
3.42
4.2
3.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
116
2.19
3.25
1.6
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
171
1.97
3.23
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
150
1134
1.39
3.22
3.6
2.8
e6/l
1.0
1.0
0.02
94
654
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
22
97
2.30
3.22
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
28
138
2.06
3.14
1.2
1.8
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
99
699
1.47
3.08
1.7
1.7
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
22
100
2.23
3.01
2.1
1.8
g/l
0.9
0.8
0.13
15
78
(3004451) EKG impression Narrative
12
40
3.03
2.98
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
163
1269
1.35
2.91
1.2
1.2
u/ml
1.1
1.9
0.66
52
359
(3019309) Folate [Moles/volume] in Red Blood Cells
153
1182
1.36
2.87
1.9
1.7
nmol/l
1132.7
1167.9
0.18
113
886
(3042936) Bacteria identified in Isolate by Culture
131
987
1.39
2.87
1.9
2.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
23
109
2.14
2.87
3.6
3.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
140
1074
1.36
2.75
3.7
2.9
e6/l
2.1
1.5
0.27
82
596
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
89
632
1.46
2.71
2.3
2.5
u/l
30.9
33.2
0.40
77
542
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
37
3.00
2.70
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
105
771
1.41
2.67
1.6
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
21
99
2.15
2.66
1.5
1.3
mmol/l
73.8
60.3
0.77
15
82
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
64
426
1.54
2.66
1.7
1.6
—
—
—
0
0
(4035726)
80
559
1.48
2.65
1.3
1.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
161
1274
1.33
2.58
5.1
3.7
ng/l
1849.6
409.1
0.43
125
1020
(3000093) Morphology [Interpretation] in Blood Narrative
12
44
2.75
2.55
1.1
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
15
62
2.45
2.55
1.4
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
57
374
1.56
2.53
12.9
13.0
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
115
2.03
2.53
1.1
1.1
iu/ml
252.6
9.4
—
7
25
(3019832) Treponema pallidum Ab [Presence] in Serum
55
359
1.57
2.50
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
124
948
1.36
2.49
1.5
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
8
21
3.84
2.46
1.0
1.0
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
57
2.48
2.46
1.4
1.4
g/l
2.2
2.8
—
7
40
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
57
2.48
2.46
1.4
1.4
g/l
5.7
6.8
—
7
41
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
57
2.48
2.46
1.4
1.4
g/l
0.4
0.3
—
7
40
(3022145) Colonoscopy Study observation
103
768
1.39
2.41
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
25
132
1.92
2.38
1.2
1.1
—
—
—
0
0
(3016330) Potassium [Moles/time] in 24 hour Urine
5
8
6.28
2.37
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
646
6075
1.28
2.35
22.5
15.0
%
45.8
40.6
20.00
410
4411
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
24
126
1.93
2.32
1.2
1.2
u/ml
334.6
292.7
0.28
18
73
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
27
148
1.85
2.31
1.5
1.5
—
—
—
0
0
(4062490)
14
59
2.40
2.30
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
44
280
1.60
2.24
4.4
4.1
mmol/l
25.0
24.9
0.08
39
262
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
342
3016
1.23
2.20
4.8
4.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
12
48
2.52
2.19
1.1
1.4
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
63
438
1.47
2.17
5.4
3.0
e9/l
4.8
4.1
1.21
43
335
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
353
3127
1.22
2.17
4.7
4.6
ug/l
1.8
2.4
1.98
315
2812
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
30
174
1.75
2.16
3.0
3.1
g/l
0.0
0.0
0.00
30
161
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
16
74
2.18
2.15
2.9
3.2
nmol/l
5.2
5.6
0.06
16
74
(3051387) C reactive protein [Mass/volume] in Capillary blood
25
137
1.85
2.15
3.4
3.8
mg/l
9.9
24.1
4.21
17
87
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
19
3.71
2.15
1.0
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
15
68
2.23
2.12
1.3
1.3
—
—
—
0
0
(4027681)
11
43
2.58
2.10
1.6
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
30
176
1.73
2.08
3.0
3.1
g/l
0.0
0.0
0.00
30
162
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
69
2.20
2.05
1.0
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
15
4.02
2.04
1.0
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
12
50
2.42
2.03
1.1
1.1
mg/l
46.3
43.9
—
6
42
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
12
50
2.42
2.03
1.5
1.2
mmol/l
11.7
13.4
—
7
19
(3044290) Cell count panel - Cerebral spinal fluid
22
118
1.89
2.03
1.3
1.2
—
—
—
0
0
(4306422)
19
98
1.96
1.96
1.4
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
31
188
1.67
1.93
3.2
3.1
g/l
0.0
0.0
0.06
31
174
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
10
39
2.58
1.92
1.0
1.1
u/l
0.9
1.1
—
5
18
(3023419) Bacteria identified in Sputum by Culture
19
99
1.94
1.91
2.0
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
26
151
1.75
1.89
5.1
2.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
52
359
1.48
1.88
1.3
1.2
iu/ml
159.2
147.5
0.05
14
142
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
222
1.60
1.85
3.0
2.8
g/l
10.2
10.6
0.23
35
192
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
59
2.22
1.85
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
104
812
1.32
1.85
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
10
222
0.44
1.85
1.2
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
69
505
1.40
1.84
2.0
1.9
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
30
183
1.66
1.84
1.3
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
10
40
2.52
1.84
1.8
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
17
3.55
1.84
2.5
1.5
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
12
4.19
1.82
1.8
2.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
180
1510
1.25
1.81
1.5
1.5
nmol/l
18.5
20.0
0.81
157
1276
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
29
2.78
1.79
2.5
2.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
47
2.36
1.78
3.0
4.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
6
18
3.35
1.75
1.2
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
41
274
1.52
1.75
1.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
9
36
2.52
1.74
1.6
3.8
nmol/l
65.7
84.0
—
9
36
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
31
194
1.62
1.74
3.2
2.9
g/l
37.2
37.4
0.06
31
168
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
148
1.71
1.72
1.4
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.86
1.71
1.0
2.1
%
50.8
87.4
—
5
7
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.86
1.71
1.0
1.1
%
48.2
110.4
—
5
13
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
5
13
3.86
1.71
1.0
1.1
%
44.0
96.0
—
5
7
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
42
284
1.50
1.70
1.9
1.9
ug/l
0.8
2.4
0.92
36
247
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
37
244
1.54
1.68
2.9
2.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
81
619
1.34
1.68
2.6
2.3
ug/l
10.2
7.7
0.26
69
555
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
19
3.17
1.66
1.2
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
19
3.17
1.66
1.2
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
13
62
2.11
1.66
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
92
719
1.31
1.64
2.0
2.4
ug/g
102.1
121.4
0.52
76
584
(3025941) Bacteria identified in Stool by Culture
47
329
1.45
1.62
1.3
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
762
7404
1.35
1.61
32.8
20.5
e9/l
243.7
244.2
0.05
753
7216
(3014271) Vancomycin [Susceptibility]
10
43
2.34
1.60
4.3
2.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
762
7406
1.34
1.58
32.7
20.4
fl
90.0
91.1
5.29
754
7295
(3042733) HLA Ab [Presence] in Serum
7
26
2.71
1.58
4.7
5.0
—
—
—
0
0
(3035941) MCH [Entitic mass]
762
7407
1.34
1.57
32.7
20.4
pg
29.9
30.4
6.23
754
7295
(3026361) Erythrocytes [#/volume] in Blood
762
7408
1.34
1.56
32.9
20.5
e12/l
5.3
4.6
117.60
749
7200
(3010813) Leukocytes [#/volume] in Blood
762
7409
1.34
1.55
33.0
20.5
e9/l
7.7
6.8
17.46
749
7199
(3000963) Hemoglobin [Mass/volume] in Blood
762
7410
1.34
1.54
33.2
20.6
g/l
156.5
138.0
99.81
753
7295
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
18
100
1.82
1.54
1.4
1.2
u/ml
5.0
6.6
—
9
45
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
39
267
1.48
1.51
2.1
1.9
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
154
1.64
1.51
1.2
1.4
miu/ml
156.6
214.1
—
8
71
(1002224) Polysomnography panel
44
309
1.45
1.51
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
72
1.96
1.49
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
87
685
1.30
1.48
1.7
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
22
132
1.68
1.47
2.5
2.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
16
87
1.86
1.46
1.3
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
41
286
1.46
1.46
1.9
2.0
u/l
42.3
38.5
0.49
35
250
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
156
1.62
1.45
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
13
66
1.99
1.44
2.0
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
72
555
1.33
1.43
2.0
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
234
2062
1.19
1.42
2.6
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
433
4013
1.16
1.40
3.0
2.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
17
2.95
1.36
1.6
1.5
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
14
75
1.88
1.35
5.1
4.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
35
241
1.47
1.34
2.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
24
2.51
1.30
1.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
161
1.57
1.30
2.0
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
34
2.37
1.29
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
277
1.43
1.29
1.1
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
203
1783
1.18
1.28
1.5
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
27
179
1.53
1.25
2.3
2.9
umol/l
31.1
35.0
0.40
22
148
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
25
2.41
1.24
2.8
4.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
25
2.41
1.24
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
25
2.41
1.24
1.2
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
45
2.01
1.23
1.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
19
2.64
1.21
1.0
2.7
%
136.8
124.1
—
5
19
(3024471) HLA-A [Type]
6
26
2.32
1.19
1.0
1.0
—
—
—
0
0
(44813793)
8
38
2.12
1.18
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
38
2.12
1.18
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
38
2.12
1.18
1.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
64
1.89
1.18
1.0
1.1
u/ml
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
34
0.00
1.16
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
58
449
1.31
1.16
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
13
72
1.82
1.15
1.2
1.9
—
—
—
0
0
(44790049)
13
72
1.82
1.15
1.9
1.7
—
—
—
0
0
(44790048)
13
72
1.82
1.15
1.9
1.7
—
—
—
0
0
(44806118)
13
72
1.82
1.15
1.9
1.7
—
—
—
0
0
(44790047)
13
72
1.82
1.15
1.9
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
52
397
1.33
1.14
1.7
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
43
319
1.37
1.13
4.0
3.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
40
2.01
1.12
2.6
3.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
12
66
1.83
1.09
1.2
2.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
8
41
1.96
1.09
2.9
2.4
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
7
32
2.20
1.08
1.1
1.2
u/l
34.9
23.1
—
7
23
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
7
32
2.20
1.08
1.1
1.2
u/l
118.5
87.8
—
7
23
(3028707) Methadone [Presence] in Urine by Screen method
16
97
1.66
1.07
2.4
3.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
34
245
1.40
1.07
3.1
3.6
g/l
0.4
0.2
0.78
23
111
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
74
1.77
1.07
1.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
33
2.13
1.05
1.1
1.1
iu/ml
179.3
288.0
—
7
33
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
33
2.13
1.05
1.6
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
41
307
1.35
1.04
1.1
1.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
196
1.44
1.03
1.9
2.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
11
60
1.84
1.03
3.2
2.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
34
2.07
1.03
1.1
1.8
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
68
1.78
1.01
1.9
2.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
123
1.56
1.00
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
123
1.56
1.00
1.8
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
35
2.01
1.00
1.1
1.1
nmol/l
161.7
142.5
—
7
35
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
132
0.53
0.99
1.4
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
61
1.81
0.98
1.2
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
23
2.18
0.98
1.2
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
275
2519
1.14
0.98
4.1
3.9
%
22.0
21.0
0.56
127
1117
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
50
631
0.78
0.94
1.8
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
1.1
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
62
1.78
0.94
1.1
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
31
418
0.73
0.93
1.5
1.4
—
—
—
0
0
(4268621)
12
70
1.72
0.93
2.4
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
10
55
1.83
0.92
1.1
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
6
28
2.15
0.91
1.2
2.9
%
70.0
101.1
—
6
28
(3000764) Benzodiazepines [Presence] in Urine
29
210
1.39
0.91
1.9
2.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
94
1.61
0.91
1.9
2.8
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
83
695
1.22
0.90
4.0
4.5
ug/l
4.7
26.7
1.18
75
586
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
237
1.36
0.89
2.4
3.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
42
1.91
0.88
1.0
1.0
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
6
30
2.01
0.87
1.2
1.1
—
25.4
—
0
5
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
6
30
2.01
0.87
5.8
6.8
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
187
1.40
0.86
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
213
1.37
0.85
1.9
2.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
213
1.37
0.85
1.9
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
26
188
1.40
0.84
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
114
0.52
0.83
2.0
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
455
1.25
0.82
1.5
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
189
1.39
0.82
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
139
1.45
0.80
2.6
3.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
22
156
1.42
0.79
1.2
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
8
48
1.67
0.79
1.3
1.4
—
24.4
—
0
7
(40761535) Cells panel - Urine sediment
43
538
0.79
0.78
4.0
3.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
18
123
1.47
0.78
1.3
1.5
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
34
1.77
0.76
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
39
306
1.29
0.76
3.1
2.7
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
0
28
0.00
0.76
0.0
2.0
—
1052.0
—
0
23
(3016018) Differential panel - Cerebral spinal fluid
10
59
1.70
0.76
1.5
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
15
99
1.52
0.76
2.1
2.6
—
489.2
—
0
9
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
83
1.58
0.75
1.2
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
28
210
1.34
0.74
1.9
2.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
9
54
1.67
0.74
1.0
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
25
2.01
0.72
1.0
1.0
miu/ml
2023.4
1541.6
—
5
25
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
18
126
1.44
0.70
1.2
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
7
41
1.71
0.70
2.3
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
27
204
1.33
0.69
1.5
1.6
—
—
—
0
0
(4146454)
13
85
1.54
0.69
3.4
2.6
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
61
1.65
0.68
1.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
42
1.67
0.68
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
10
156
0.64
0.68
1.1
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
102
1.48
0.68
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
545
0.82
0.64
1.6
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
30
1.67
0.61
1.8
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
113
1.42
0.61
1.0
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
21
0.00
0.60
0.0
1.9
—
5224.1
—
0
12
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
0
22
0.00
0.59
0.0
1.3
—
14.3
—
0
16
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
34
273
1.26
0.59
2.2
3.8
u/ml
146.2
5111.1
0.74
28
232
(4094501)
25
193
1.30
0.58
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
55
1.46
0.56
1.1
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
23
178
1.30
0.53
1.7
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
63
1.43
0.52
2.6
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
15
109
1.38
0.51
1.3
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
189
1.28
0.50
1.3
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
73
825
0.87
0.49
5.0
4.6
%
27.3
31.1
2.92
53
553
(3045414) Leukocytes [Presence] in Urine
33
271
1.23
0.49
2.3
1.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
53
612
0.86
0.48
1.3
1.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
50
1.40
0.45
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
10
69
1.45
0.44
1.1
1.4
u/l
11.2
26.5
—
10
56
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
51
1.38
0.44
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
113
1.33
0.43
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
2.8
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.7
—
10.3
—
0
13
(3011397) Hemoglobin [Presence] in Urine by Test strip
154
1439
1.09
0.39
4.0
3.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
35
1.43
0.39
1.4
1.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
19
151
1.26
0.38
1.1
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
66
1.37
0.38
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
10
73
1.37
0.34
1.2
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
21
172
1.23
0.34
1.4
1.6
e6/l
16385.4
16519.5
0.01
14
127
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
113
1051
1.09
0.33
1.3
1.3
iu/ml
16.0
31.6
3.68
37
314
(21494815) CD4 cells/100 lymphocytes in Specimen
6
47
1.28
0.32
1.7
2.0
—
39.6
—
0
7
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
16
197
0.81
0.31
1.5
1.6
iu/ml
0.0
0.1
—
5
37
(3019225) pH of Specimen
70
639
1.10
0.31
4.5
4.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
147
1.23
0.31
1.2
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.0
1.3
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
107
0.75
0.29
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
107
0.75
0.29
1.3
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
15
122
1.23
0.27
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
9
72
1.25
0.25
3.0
4.0
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
27
235
1.15
0.25
2.6
2.7
u/ml
23.5
49.3
1.19
27
224
(3044927) Protein electrophoresis panel - Urine
9
74
1.22
0.25
1.3
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
87
1.27
0.24
1.1
1.1
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
39
1.28
0.23
1.2
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
40
1.25
0.22
1.0
1.2
u/l
14.6
12.8
—
5
33
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
106
1003
1.07
0.22
1.2
1.3
u/ml
3.7
10.9
1.80
43
400
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
165
1583
1.05
0.22
2.6
2.4
—
—
—
0
0
(3035880) pH of Pleural fluid
5
41
1.22
0.22
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
21
241
0.87
0.21
1.6
1.6
mg/l
2.5
3.3
0.33
16
176
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
42
1.19
0.21
1.0
1.2
u/l
63.2
72.9
—
5
36
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.5
—
49.1
—
0
6
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.9
—
76.9
—
0
10
(3052592) Norovirus Ag [Presence] in Stool
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
190
1832
1.05
0.21
3.1
2.8
ug/l
0.7
0.7
0.17
125
1143
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
43
1.16
0.21
1.6
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
147
1409
1.05
0.20
4.1
3.7
kg/l
1.0
1.0
1.06
28
201
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
14
0.00
0.20
0.0
5.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
14
0.00
0.20
0.0
2.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
3.1
—
37.4
—
0
7
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
58
1.21
0.18
1.3
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
368
1.09
0.17
1.2
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
20
176
1.14
0.17
1.5
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
18
157
1.15
0.17
12.2
10.0
mmol/l
11.7
11.6
0.04
18
142
(3018572) Chloride [Moles/volume] in Blood
18
157
1.15
0.17
12.2
10.0
mmol/l
104.7
105.4
0.27
18
142
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
18
157
1.15
0.17
1.2
1.2
—
1.9
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
10
82
1.22
0.17
1.3
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
49
456
1.08
0.17
2.2
2.5
—
13.6
—
0
25
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
67
0.74
0.17
1.6
2.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
17
148
1.15
0.17
1.2
1.2
—
6.2
—
0
21
(3012441) Differential panel - Pleural fluid
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
8
70
1.14
0.16
1.1
1.4
mmol/l
7.7
6.3
—
8
64
(3033705) Calcium.ionized [Moles/volume] in Venous blood
11
92
1.20
0.16
1.6
2.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
13
111
1.17
0.16
1.4
1.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
78
1.16
0.15
1.2
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
25
274
0.91
0.14
1.2
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
180
1.11
0.13
2.0
1.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
189
0.90
0.12
1.4
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
40
423
0.94
0.10
1.1
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
125
0.88
0.10
1.2
1.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
20
183
1.10
0.10
1.2
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
193
1.09
0.10
1.3
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
45
1.11
0.10
1.2
1.3
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
114
0.88
0.09
1.2
1.2
—
1.1
—
0
8
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
5
47
1.06
0.09
1.2
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
6
54
1.11
0.09
1.0
1.0
—
—
—
0
0
(4024509)
6
56
1.07
0.08
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
224
1.07
0.08
2.1
1.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
63
0.79
0.08
1.2
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
7
65
1.08
0.08
1.1
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
66
1.06
0.08
1.1
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
11
98
1.12
0.07
1.7
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
6
70
0.86
0.07
1.8
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
15
137
1.10
0.07
1.8
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
91
0.88
0.06
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
91
0.88
0.06
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
92
0.87
0.06
1.0
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
21
223
0.94
0.06
1.3
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
32
308
1.04
0.04
2.3
2.4
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
101
1.09
0.04
1.2
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
55
539
1.02
0.03
2.4
2.5
ml/min/173m2
56.1
66.9
1.23
25
201
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
24
231
1.04
0.03
2.2
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
118
0.93
0.02
1.1
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
83
819
1.01
0.02
11.1
6.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
17
177
0.96
0.01
5.9
4.4
—
—
—
0
0
(4034850)
22
218
1.01
0.00
22.2
10.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
125
1.04
0.00
1.2
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
198.0
—
0
5
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
9
0.00
0.00
0.0
1.0
—
17.8
—
0
9
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
49
1.02
0.00
1.2
1.8
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
9
92
0.98
0.00
1.1
1.5
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
1.8
—
0
6
(3011648) Oxygen content in Venous blood
5
55
0.91
0.00
1.0
1.6
%
10.6
10.8
—
5
55
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
69
0.87
0.00
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
5
56
0.89
0.00
1.0
1.7
mg/l
7.0
3.7
—
5
56
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
9
92
0.98
0.00
1.1
1.5
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
9
90
1.00
0.00
1.1
1.5
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
8
81
0.99
0.00
4.1
3.1
u/ml
52.8
18.4
—
8
81
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
69
1.01
0.00
2.4
2.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_SCNDPOLYCYTHAEMIA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SCNDPOLYCYTHAEMIA | 2.337 [1.94, 2.81] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.556 |
During the follow-up period (1.1.1998 — 31.12.2019), 330 out of 1298 females with D3_SCNDPOLYCYTHAEMIA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| D3_SCNDPOLYCYTHAEMIA | 1.929 [1.65, 2.25] | < 0.001 |
| Birth year | 0.985 [0.98, 0.99] | 0.002 |
During the follow-up period (1.1.1998 — 31.12.2019), 574 out of 2522 males with D3_SCNDPOLYCYTHAEMIA died.
Mortality risk
Mortality risk for people of age
years, who have D3_SCNDPOLYCYTHAEMIA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.314% | 0.369% |
| 5 | 1.509% | 2.132% |
| 10 | 3.477% | 5.162% |
| 15 | 6.641% | 10.023% |
| 20 | 12.368% | 16.089% |
Relationships between endpoints
↥Index endpoint: D3_SCNDPOLYCYTHAEMIA – Secondary polycythaemia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data